Thursday, December 10th, 2015

P3-05-06 Session Title: Tumor Cell and Molecular Biology: Endocrine Therapy and Resistance

Evolution of genomic alterations on endocrine therapy and mTOR inhibition in estrogen receptor (ER)-positive breast cancer

Session Time: 5–7pm CT

Presenter / Collaborators: Suleiman Massarweh, MD, Stanford Cancer Institute / Stanford University Medical School and Stanford Cancer Institute, Stanford, CA; University of Kentucky and Markey Cancer Center, Lexington, KY

[View Abstract]

P3-07-05 Session Title: Prognostic and Predictive Factors: Response Predictions -- Biomarkers and Other Factors

Non-Amplification ERBB2 Genomic Alterations in 5,605 Cases of Refractory and Metastatic Breast Cancer: an Emerging Opportunity for anti-HER2 Targeted Therapies

Session Time: 5–7pm CT

Presenter / Collaborator: Jeffrey S. Ross, MD, Medical Director, Foundation Medicine / Albany Medical College

[View Abstract]

Friday, December 11th, 2015

PD6-08 Poster discussion: Translational Genomics

IMAGE: Individualized molecular analyses guide efforts in breast cancer with comprehensive genomic profiling of tissue and plasma tumor DNA

Session Time: 5–7pm CT

Presenter / Collaborators: Benjamin Park, MD, PhD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center / The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine

[View Abstract]

 

P5-14-06 Session Title: Treatment: Advanced Endocrine Therapy

Lapatinib reverses endocrine resistance in select patients with HER 2 negative, Hormone positive metastatic breast cancer

Session Time: 5–7pm CT

Presenter / Collaborator: Priyanka Sharma, MD, MD Anderson Cancer Center / MD Anderson Cancer Center Institute

[View Abstract]

 

Saturday, December 12th, 2015

P6-03-12 Poster Session: Tumor Cell and Molecular Biology: Genomics

Comprehensive Genomic Profiling of Clinically Advanced Mucinous Carcinoma of the Breast

Session Time: 7:30–9am CT

Presenter / Collaborator: Siraj M. Ali, MD PhD, Associate Director, Clinical Development and Medical Affairs, Foundation Medicine / Albany Medical College

[View Abstract]

 

P6-07-06 Session Title: Tumor Cell and Molecular Biology: Genetics -- Somatic Changes

Clinicopathologic characterization and Comprehensive Genomic Profiling of Advanced Breast Cancer Patients with Fibroblast Growth Factor Receptor (FGFR) Alterations

Session Time: 7:30–9am CT

Presenter: Ricardo Alvarez, MD, Cancer Treatment Centers of America

[View Abstract]

P6-03-02 Session Title: Tumor Cell and Molecular Biology: Genomics

EGFR Genomic Alterations in 5,605 Cases of Refractory and Metastatic Breast Cancer

Session Time: 7:30–9am CT

Presenter / Collaborators: Siraj M. Ali, MD PhD, Associate Director, Clinical Development and Medical Affairs, Foundation Medicine / Mayo Clinic, Albany Medical College, Houston Methodist Hospital

[View Abstract]